Selective estrogen-receptor modulators for primary prevention of breast cancer

被引:71
作者
Fabian, CJ
Kimler, BF
机构
[1] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, KS 66160 USA
关键词
D O I
10.1200/JCO.2005.11.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1644 / 1655
页数:12
相关论文
共 207 条
[1]   Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein [J].
Allred, CD ;
Ju, YH ;
Allred, KF ;
Chang, J ;
Helferich, WG .
CARCINOGENESIS, 2001, 22 (10) :1667-1673
[2]   Histological and biological evolution of human premalignant breast disease [J].
Allred, DC ;
Mohsin, SK ;
Fuqua, SAW .
ENDOCRINE-RELATED CANCER, 2001, 8 (01) :47-61
[3]  
Allred DC, 2002, BREAST CANCER RES TR, V76, pS36
[4]   Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens [J].
An, JP ;
Tzagarakis-Foster, C ;
Scharschmidt, TC ;
Lomri, N ;
Leitman, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :17808-17814
[5]  
ANKER G, 1995, INT J CANCER, V60, P365
[6]  
ANZANO MA, 1994, CANCER RES, V54, P4614
[7]   Chemoprevention of mammary carcinogenesis in the rat: Combined use of raloxifene and 9-cis-retinoic acid [J].
Anzano, MA ;
Peer, CW ;
Smith, JM ;
Mullen, LT ;
Shrader, MW ;
Logsdon, DL ;
Driver, CL ;
Brown, CC ;
Roberts, AB ;
Sporn, MB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (02) :123-125
[8]   Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles [J].
Baker, VL ;
Draper, M ;
Paul, S ;
Allerheiligen, S ;
Glant, M ;
Shifren, J ;
Jaffe, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :6-13
[9]   Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases [J].
Bardou, VJ ;
Arpino, G ;
Elledge, RM ;
Osborne, CK ;
Clark, GM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) :1973-1979
[10]   Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial [J].
Barrett-Connor, E ;
Grady, D ;
Sashegyi, A ;
Anderson, PW ;
Cox, DA ;
Hoszowski, K ;
Rautaharju, P ;
Harper, KD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :847-857